title: Advanced strategies of short-term prophylaxis in menstrual migraine: state of the art and prospects.
abstract: Patients suffering from menstrual migraine (MM) may be ideal candidates for an intermittent prophylaxis, usually termed short-term or mini-prophylaxis. It covers the whole period of vulnerability, e. g., the perimenstrual period, starting some days before the expected onset of MM attack. Theoretically MM attacks are an optimal target for drugs specifically developed for acute head pain. Unfortunately, due to their particular tendency to be longer, more intense and less responsive to analgesics, symptomatic approaches alone are not often able to completely control pain and its correlates. Many drugs have been proposed for short-term prophylaxis of MM. In this paper we analyse only non-steroidal anti-inflammatory drugs, coxibs and triptans (especially those with longer half-life, naratriptan and frovatriptan). Moreover, MM can be prevented by a variety of hormonal manipulations, including oral contraceptives, which may be administered with an extended-dosing strategy; oestrogen replacement therapy; antioestrogen agents (danazol, tamoxifen); gonadotropin-releasing hormone agonists followed by oestrogen add-back therapy. Finally, the use of some products, such as magnesium and phytoestrogens, that probably meet the requirements of those patients that appreciate a more "natural" approach, is discussed.
authors.affiliation: Woman's Headache Center, Department of Gynecology and Obstetrics, University of Turin, Via Ventimiglia 3, I-10126, Turin, Italy. gb.allais@tiscali.it
authors.forename: G
authors.initials: G
authors.lastname: Allais
authors.forename: G
authors.initials: G
authors.lastname: Bussone
authors.forename: C
authors.initials: C
authors.lastname: De Lorenzo
authors.forename: O
authors.initials: O
authors.lastname: Mana
authors.forename: C
authors.initials: C
authors.lastname: Benedetto
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D016861:Cyclooxygenase Inhibitors / Q000627:therapeutic use; D004412:Dysmenorrhea / Q000517:prevention & control*; D005260:Female; D020249:Hormone Replacement Therapy / Q000379:methods; D006801:Humans; D008881:Migraine Disorders / Q000517:prevention & control*; D011315:Preventive Medicine; D017366:Serotonin Receptor Agonists / Q000627:therapeutic use; D013997:Time Factors
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D016861:Cyclooxygenase Inhibitors; D017366:Serotonin Receptor Agonists